Advertisement

Topics

Nonproliferative retinopathy - Biotech, Pharma and Life Science Channel

07:03 EDT 27th April 2017 | BioPortfolio

PubMed Articles [408 Associated PubMed Articles listed on BioPortfolio]

Impact of intravitreal pharmacotherapies including antivascular endothelial growth factor and corticosteroid agents on diabetic retinopathy.

Diabetic retinopathy is common and increasing in prevalence. Pharmacologic management of diabetic macular edema (DME) has improved tremendously over the last decade with the use of two families of int...

Serum Uric Acid Levels are Associated with Increased Risk of Newly Developed Diabetic Retinopathy Among Japanese Male Patients With Type 2 Diabetes: A Prospective Cohort Study Diabetes Distress and Care Registry at Tenri (DDCRT 13).

We assessed the prospective association between baseline serum uric acid (SUA) levels and consequent risk of developing diabetic retinopathy (DR).

Academic Performance, Motor Function, and Behavior 11 Years After Neonatal Caffeine Citrate Therapy for Apnea of Prematurity: An 11-Year Follow-up of the CAP Randomized Clinical Trial.

Caffeine citrate therapy for apnea of prematurity reduces the rates of bronchopulmonary dysplasia, severe retinopathy, and neurodevelopmental disability at 18 months and may improve motor function at ...

Diabetic Retinopathy and Clinical Parameters Favoring the Presence of Diabetic Nephropathy could Predict Renal Outcome in Patients with Diabetic Kidney Disease.

Diabetes duration, diabetic retinopathy (DR), and a diagnostic model have been proposed as clinical parameters favoring the presence of diabetic nephropathy (DN) in biopsied patients with diabetic kid...

Erratum. Diabetic Retinopathy: A Position Statement by the American Diabetes Association. Diabetes Care 2017;40:412-418.

Axial Length and Anterior Segment Alterations in Former Preterm Infants and Full-Term Neonates Analyzed With Scheimpflug Imaging.

To compare the axial length and anterior segment alterations in preterm infants with and without retinopathy of prematurity with those of full-term infants.

Screening for Diabetic Retinopathy.

Frequency of Evidence-Based Screening for Retinopathy in Type 1 Diabetes.

Background In patients who have had type 1 diabetes for 5 years, current recommendations regarding screening for diabetic retinopathy include annual dilated retinal examinations to detect proliferativ...

Optimal screening schedules for disease progression with application to diabetic retinopathy.

Clinical management of chronic diseases requires periodic evaluations. Subjects transition between various levels of severity of a disease over time, one of which may trigger an intervention that requ...

Rapid Assessment of Avoidable Blindness and Diabetic Retinopathy in Gilan Province, Iran.

To conduct an assessment of avoidable blindness and diabetic retinopathy (DR) in Gilan, 2014.

News Articles [161 Associated News Articles listed on BioPortfolio]

Artificial Intelligence Shows Potential to Fight Blindness

SAN FRANCISCO, April 27, 2017 /PRNewswire-USNewswire/ -- Researchers from the Byers Eye Institute at Stanford University have found a way to use artificial intelligence to fight a complication of...

Retina Group of New York to Exhibit at No-Cost Bellport Low Vision/Technology Fair for Visually Impaired

The Suffolk Cooperative Library System Outreach Program will sponsor a free Low Vision/Technology Fair for the Visually Impaired and Blind on May 5th, 2017 from 9AM to 3 PM in Bellport, NY. Vendors wi...

Flatbush Community Health Expo and Diabetes Symposium Features Diabetic Retinopathy Education and Screening by Retina Group of New York

Retina Group of New York (RGONY) is pleased to be a sponsor, speak about “Diabetic Retinopathy Prevention, Detection and Treatment” and provide no-cost retinopathy screening at the Island of Flatb...

Retinal Surgery Devices Market Size Worth $3.06 Billion By 2025: Grand View Research, Inc.

SAN FRANCISCO, April 24, 2017 /PRNewswire/ -- The global retinal surgery devices market is expected to reach USD 3.06 billion by 2025, according to a new report by Grand View Research, I...

Target Identified for Abnormal Blood Vessel Growth in the Eyes

News These findings pave the way for new therapies that address diabetic retinopathy and other conditions involving abnormal vessel growth within the retina.

Tailored screenings for retinopathy in patients with diabetes could save millions of dollars

Fewer eye examinations may be needed for patients with type 1 diabetes, which could result in substantial long-term cost savings, according to a study.Using retinal photographs from the Diabetes Contr...

Global Optical Coherence Tomography Market 20172021 [Updated: 13032017] Prices from USD $3500

About OCTOCT can help to identify diseases such as diabetic retinopathy and glaucoma at the granular level by providing the images of the retina in layers, which can help physicians identify the disea...

IBM Machine Vision Technology Advances Early Detection of Diabetic Eye Disease Using Deep Learning

MELBOURNE, Australia, April 20, 2017 /PRNewswire/ -- IBM (NYSE: IBM) this week released the results of new research using deep learning and visual analytics technology to advance early detec...

Fewer exams and better eye health? Aye-aye, finds type 1 diabetes study

Adjusting the frequency of eye screenings for people with type 1 diabetes based on their risk of severe eye problems would result in fewer eye exams at lower cost and quicker diagnosis and treatment o...

Targeted Retinopathy Screening Proposed in Type 1 Diabetes

Long-term data from the Diabetes Control and Complications Trial and its follow-up suggest retina exam frequency can be individualized based on initial degree of retinopathy and HbA1c. Medscape Med...

Events [0 Results]

None

Companies [7 Associated Companies listed on BioPortfolio]

Aerpio Pharmaceuticals, Inc.

Aerpio Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing first-in-class treatments for ocular diseases. The Company’s lead program, AKB‐9778, is ...

Acucela Inc.

Acucela Inc. is a clinical-stage biotechnology company focused on leveraging promising science in visual cycle modulation (VCM) to develop new methods for treating blinding eye di...

Optos plc

Optos plc is a leading medical retinal imaging technology company. Both eye and non-eye diseases often first exhibit in the periphery of the retina. These are very difficult to de...

Promedior, Inc.

Promedior has developed a novel drug discovery platform to regulate the monocyte-derived cell populations that play key roles in fibrotic, inflammatory and autoimmune diseases. By...

NormOxys, Inc.

NormOxys is developing a novel class of small molecule drugs, oxyrens, which enhance the body’s ability to deliver oxygen more efficiently to diseased tissues with oxygen def...

Acucela

Acucela Inc. (www.acucela.com) is a clinical-stage biotechnology company focused on leveraging promising science in visual cycle modulation (VCM) to develop new methods for...

Allegro Ophthalmics, LLC

With more than 100 years of combined experience in vision science and medicine, the leadership team at Allegro Ophthalmics, LLC is establishing Integrin Peptide Therapy as the ...

Clinical Trials [258 Associated Clinical Trials listed on BioPortfolio]

Serum Vascular Endothelial Growth Factor in Infants With Intravitreal Ranibizumab

To determine the serum concentrations of ranibizumab and vascular endothelial growth factor (VEGF) in infants with retinopathy of prematurity (ROP) who received intravitreal ranibizumab

The Individually-Marked Panretinal Laser phoTocoagulation for Proliferative Diabetic Retinopathy Study (TREAT)

Background Diabetic eye disease is the most frequent complication among the 320,000 Danes with diabetes. The formation of new vessels (PDR) in the inner part of the eye (retina) is a feare...

Metabolomics in Surgical Ophthalmological Patients

Metabolomics consists in the study of metabolites in body fluids or tissues. It investigates the consequences of the activity of genes and proteins. One of its advantages is that it is abl...

PROTECT2 - See Official Title for Response to PRS Review Comments [1]

The PROTECT2 pilot study is a single cohort prospective study to gather pilot data and finalize operational details of the main study. The PROTECT2 main study is a prospective randomized ...

The Effect of A2A Adrenoceptor Stimulation on the Diameter of Retinal Arterioles During Hypoxia in Vivo

The purpose is to investigate how the adenosine affects the diameter regulation of retinal arterioles during changes in oxygen tension. A deeper understanding of the mechanisms involved in...

Intravitreal Aflibercept Injection for Radiation Retinopathy Trial

The ARRT trial will assess the safety and efficacy of 2mg aflibercept for the treatment of radiation retinopathy, including maculopathy and optic neuropathy over 52 weeks.

Propranolol for Prevention of Threshold Retinopathy of Prematurity

Extremely premature infants are at risk of developing a potentially blinding eye disease, called retinopathy of prematurity (ROP). Currently available treatment, consisting of laser surger...

The PUPIL Study - Automated, Quantitative Pupil Assessment Using Binocular OCT

In current, clinical ophthalmology, a range of specialised testing allows comprehensive evaluation of ocular health. These tests have typically evolved over many years to ensure their clin...

Pilot Assessment of EyeArt as an Automated Diabetic Retinopathy Screening Tool

More than 29 million people in the US are living with diabetes, many of whom will develop diabetic retinopathy (DR) or diabetic eye disease (DED), the leading cause of vision loss and blin...

A Study to Evaluate the Safety and Efficacy of THR-317 for the Treatment of Diabetic Macular Oedema (DME)

This study is conducted to evaluate the safety of THR-317 when administered intravitreally and to assess the compound's efficacy in improving best-corrected visual acuity (BCVA) and reduci...

Videos

None available.

Medical and Biotech [MESH] Definitions

A bilateral retinopathy occurring in premature infants treated with excessively high concentrations of oxygen, characterized by vascular dilatation, proliferation, and tortuosity, edema, and retinal detachment, with ultimate conversion of the retina into a fibrous mass that can be seen as a dense retrolental membrane. Usually growth of the eye is arrested and may result in microophthalmia, and blindness may occur. (Dorland, 27th ed)

Degenerative changes to the RETINA due to HYPERTENSION.

A drug used to reduce hemorrhage in diabetic retinopathy.

Removal of the whole or part of the vitreous body in treating endophthalmitis, diabetic retinopathy, retinal detachment, intraocular foreign bodies, and some types of glaucoma.

Disease of the RETINA as a complication of DIABETES MELLITUS. It is characterized by the progressive microvascular complications, such as ANEURYSM, interretinal EDEMA, and intraocular PATHOLOGIC NEOVASCULARIZATION.

Quick Search
Advertisement
 
review and buy Nonproliferative retinopathy market research data and corporate reports here

Channels Quicklinks